Nippon Life backs Corebridge–Equitable merger plan
Rhea-AI Filing Summary
Nippon Life Insurance Company has amended its Schedule 13D/A on Corebridge Financial, Inc. to disclose a new Voting and Support Agreement tied to Corebridge’s planned merger with Equitable Holdings, Inc. Nippon Life beneficially owns 121,992,454 shares of Corebridge common stock, representing 26.7% of the outstanding shares based on 456,727,266 shares as of March 23, 2026.
Under the Voting and Support Agreement dated April 8, 2026, Nippon Life must, with limited qualifications, vote its Covered Stock in favor of the merger-related proposals and refrain from transferring that stock until stockholder approval, subject to certain exceptions. Nippon Life also agrees to use reasonable best efforts to obtain required regulatory and governmental approvals and keep Corebridge and Equitable informed of substantive regulatory communications.
At closing, Nippon Life and the new holding company are expected to enter a new stockholder’s agreement and a new registration rights agreement, replacing existing agreements with substantially similar terms. The filing also notes that a subsidiary, Nissay Asset Management Corporation, bought 33 shares and sold 573 shares of Corebridge stock in the open market on February 27, 2026 at $25.84 per share.
Positive
- None.
Negative
- None.
Insights
Nippon Life formally commits its 26.7% Corebridge stake to support the Equitable merger.
The amendment shows Nippon Life, holding 121,992,454 Corebridge shares (26.7% of the company as of March 23, 2026), signing a Voting and Support Agreement with Corebridge and Equitable Holdings. This aligns a major shareholder behind the previously announced merger structure using a new holding company.
The agreement obligates Nippon Life to vote its Covered Stock for the merger-related proposals, not transfer that stock before the shareholder vote except in limited cases, and use reasonable best efforts to secure regulatory and governmental approvals. It also provides for replacement stockholder and registration rights agreements at closing with terms described as substantially similar to existing arrangements.
This filing is largely governance and process-oriented rather than financial. It signals coordination among the issuer, Equitable, and a key strategic shareholder, but its effect will ultimately depend on completion of the merger and regulatory approvals described in the underlying Merger Agreement dated March 26, 2026.
Key Figures
Key Terms
Voting and Support Agreement regulatory
Covered Stock financial
Stockholder's Agreement regulatory
Registration Rights Agreement regulatory
beneficially owns financial
Agreement and Plan of Merger regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What stake in Corebridge Financial (CRBD) does Nippon Life report in this Schedule 13D/A amendment?
What is the Voting and Support Agreement involving Corebridge (CRBD), Equitable, and Nippon Life?
How does this filing describe Nippon Life’s future governance arrangements with Corebridge (CRBD)?
What does the filing say about Nippon Life’s contracts or arrangements regarding Corebridge (CRBD) stock?
How is Covered Stock defined for Nippon Life’s obligations in Corebridge (CRBD)?
AI-generated analysis. How Rhea-AI works. Not financial advice.